A

Adaptive Biotechnologies

Seattle, United States Founded 2009 NASDAQ: ADPT

About

Biotechnology company developing immune-driven medicine through sequencing

Company Details

Type
public
Employees
600+
Funding
Public

Key Products

  • clonoSEQ
  • immunoSEQ
  • T-Detect
Visit Website

Related Companies